Treatment with the proteasomal inhibitor MG-132 rescued DNA-PK protein expression in the MTA1-transfected cells (Figure 5C), indicating that DNA-PK is actively getting degraded in HCC cancer cells. The gene discussed is MTA1; the disease is hepatocellular carcinoma.